Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial
Amirhossein Gougol(Tehran University of Medical Sciences), Shahin Akhondzadeh(Arak University of Medical Sciences), Negar Iranpour(Roozbeh Hospital), Habibeh Yekehtaz(Arak University of Medical Sciences), Mehdi Farokhnia(National Institutes of Health), Samira Raheb(Roozbeh Hospital), Samrand Salimi(Tehran University of Medical Sciences), Nahid Zareh-Mohammadi(Roozbeh Hospital)
Cited by 77
Related Papers
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
|JCI Insight|2023|200
Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review
|Pharmacological Reviews|2022|155
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
|Clinical Neuropharmacology|2013|154
Comparing the efficacy and safety of<i>Crocus sativus</i>L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
|Human Psychopharmacology Clinical and Experimental|2014|151